Irvine, CA
Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.
immunisbiomedical.comThese are collections Immunis is a part of. Click on the collection name to view similar companies.
Series A
$25,000,000
Series A
$10,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Immunis.